The company's board of directors on Monday approved raising up to Rs 5,000 crore via non-convertible debentures in 3-4 distinct series with...

The company will raise up to Rs 5,000 crore through non-convertible debentures (NCDs) maturing in up to 48 months, according to a regulator...

The board has established a fundraising committee and granted them the authority to manage all aspects of raising funds, such as deciding t...

The average blended cost of the debt is likely to be around 8.50% with the firm seeking to borrow money over one- to-five years, said three...

Oravel Stays Ltd, the parent company of OYO, secured Rs 1,457 crore from several investors, including InCred Wealth, J&A Partners, and ASK ...

Mankind Pharma has appointed Barclays and Deutsche Bank to arrange financing for its Rs 13,630 crore acquisition of Bharat Serums & Vaccine...

Mankind Pharma announced a ₹13,630 crore acquisition of Bharat Serums and Vaccines (BSV) to be funded through internal accruals and a mix o...

In value terms, retail investors applied for shares worth a staggering Rs 1.49 lakh crore, which was a whopping 203% higher than the total ...

Infosys on Monday said its CFO Nilanjan Roy has resigned from the company to pursue other personal aspirations. Nilanjan will continue to b...

The strong performance of Mankind Pharma Ltd. in the stock market is expected to lead to more consumer-related initial public offerings (IP...

The primary market in India has experienced a weak first half with only eight companies launching IPOs, leading to earnings of Rs 5,800 cro...

The IPO market in India has remained steady during Q1 of 2023, with four IPOs taking place during the quarter, one higher than in the same ...

January and February did not see any public issues. The high-profile ₹20,000-crore follow-on public offering of Adani Enterprises was calle...

ET was the first to report in July last year that global and domestic PE funds were in initial discussions to purchase a minority stake in ...

Dogsee Chew said it will use the funds for brand building, R&D, and building a strong distribution network.

The fund size could go up to $950 million with the firm’s four partners also planning to contribute $50-100 million, the people added.

$200 million for its 11% holding, which if realized, with fetch a return of more than 8 times on the seven-year-old investment.